Literature DB >> 34244831

Anti-mycobacterial activity evaluation of designed peptides: cryptic and database filtering based approach.

Sneha Raj1, Umamageswaran Venugopal1, Garima Pant2, Mitra Kalyan2, Jesu Arockiaraj3, Manju Y Krishnan1, Mukesh Pasupuleti4.   

Abstract

Worldwide, TB is one of the deadly airborne diseases, which accounts for 10.4 million deaths annually. Serious toxicity issue, prolonged treatment regimens of the current drugs, rise in multidrug-resistant strains, and the unique defensive mechanism makes the development of novel therapeutic molecules against Mycobacterium tuberculosis (MT) an urgent need. As MT has a lengthy latent phase and unique cell wall architecture, a reasonable approach is needed to find molecules having a different killing mechanism rather than traditional approaches. Host defence peptides (HDPs) will be the most promising alternative, potential therapeutic candidates as they target the microbial membrane in particular and are an essential part of the innate immunity of humans. This works demonstrates the utility of "Database filtering" and three-dimensional (3D) modelling approach in finding novel AMPs with appreciable activity towards MT. Results of this study indicate that peptides with 70% hydrophobicity, but without hydrophobicity patches (> 4 hydrophobic amino acids in series) and charge of + 4 or + 5 are most likely to be good anti-tubercular candidates.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Analogous peptide; Cell membrane; Host defence peptides; Mycobacterium tuberculosis; Tuberculosis

Year:  2021        PMID: 34244831     DOI: 10.1007/s00203-021-02474-5

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  46 in total

1.  The ATPase activity of the mycobacterial plasma membrane is inhibited by the LL37-analogous peptide LLAP.

Authors:  Sandra Chingaté; Gabriela Delgado; Luz Mary Salazar; Carlos-Yesid Soto
Journal:  Peptides       Date:  2015-07-26       Impact factor: 3.750

Review 2.  Natural antimicrobial peptides against Mycobacterium tuberculosis.

Authors:  Maria Abedinzadeh; Mahdieh Gaeini; Soroush Sardari
Journal:  J Antimicrob Chemother       Date:  2015-02-12       Impact factor: 5.790

Review 3.  New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State.

Authors:  Santiago Caño-Muñiz; Richard Anthony; Stefan Niemann; Jan-Willem C Alffenaar
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

Review 4.  Antimicrobial peptides as an alternative to anti-tuberculosis drugs.

Authors:  Manaf AlMatar; Essam A Makky; Gülfer Yakıcı; Işıl Var; Begüm Kayar; Fatih Köksal
Journal:  Pharmacol Res       Date:  2017-10-25       Impact factor: 7.658

5.  Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy.

Authors:  Sylvie Alonso; Kevin Pethe; David G Russell; Georgiana E Purdy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

6.  Bacteriostatic activity of the proregion of human hepcidin.

Authors:  Christophe Barthe; Agnès Hocquellet; Bertrand Garbay
Journal:  Protein Pept Lett       Date:  2011-01       Impact factor: 1.890

7.  Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis.

Authors:  Ligia Corrales-Garcia; Ernesto Ortiz; Julio Castañeda-Delgado; Bruno Rivas-Santiago; Gerardo Corzo
Journal:  Protein Expr Purif       Date:  2013-03-01       Impact factor: 1.650

Review 8.  Latent tuberculosis infection: Opportunities and challenges.

Authors:  Cynthia B E Chee; Randall Reves; Ying Zhang; Robert Belknap
Journal:  Respirology       Date:  2018-06-14       Impact factor: 6.424

Review 9.  Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection.

Authors:  Lucy C K Bell; Mahdad Noursadeghi
Journal:  Nat Rev Microbiol       Date:  2017-11-07       Impact factor: 60.633

Review 10.  Mycobacterium tuberculosis infection of host cells in space and time.

Authors:  Claudio Bussi; Maximiliano G Gutierrez
Journal:  FEMS Microbiol Rev       Date:  2019-07-01       Impact factor: 16.408

View more
  2 in total

Review 1.  The NEK family of serine/threonine kinases as a biomarker for cancer.

Authors:  Nagesh Kishan Panchal; Sabina Evan Prince
Journal:  Clin Exp Med       Date:  2022-01-17       Impact factor: 3.984

2.  Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry.

Authors:  Nelson Enrique Arenas; Gilles Pieffet; Cristian Rocha-Roa; Martha Inírida Guerrero
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-18       Impact factor: 2.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.